{"transactions":[{"id":3807388,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director, 10% holder"}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":5,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":6,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":7,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":8,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":9,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-26T19:43:40.000Z","date":"2018-09-24","kind":"other","acquired":false,"shares":325799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund (\"Sely II\") distributed 325,799 shares to its partners on a pro rata basis, for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"As partners of Sely II, Fabio Lopez and Daniel Tafur received 6,325 and 2,372, respectively, of the shares distributed by Sely II."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-025346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000089924318025346/doc4.xml","form_type":"4"}},{"id":3807387,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director, 10% holder"}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":5,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":6,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":7,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":8,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":9,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-26T19:43:40.000Z","date":"2018-09-24","kind":"other","acquired":false,"shares":676324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund (\"Sely I\") distributed 676,324 shares to its partners on a pro rata basis, for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"As partners of Sely I, Daniel Tafur and Equilibria Capital Management received 13,871 and 107,619, respectively, of the shares distributed by Sely I."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-025346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000089924318025346/doc4.xml","form_type":"4"}},{"id":3807386,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director, 10% holder"}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":5,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":6,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":7,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":8,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":9,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-26T19:43:40.000Z","date":"2018-09-24","kind":"other","acquired":false,"shares":1521863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund (\"Sely S\") distributed 1,521,863 shares to its partners on a pro rata basis, for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As a partner of Sely S, Fabio Lopez, received 19,524 of the shares distributed by Sely S."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-025346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000089924318025346/doc4.xml","form_type":"4"}},{"id":3895608,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-13T18:30:02.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the earlier of (x) June 12, 2019 (the first anniversary of the date of grant) or (y) the day prior to the 2019 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":5500,"derivative":{"exercise_price":5.23,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-18-037550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919118037550/doc4.xml","form_type":"4"}},{"id":3994775,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-15T19:59:52.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares will vest and became exercisable in equal monthly installments for thirty-six (36) months following the March 13, 2018 grant date, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":11000,"derivative":{"exercise_price":5.24,"expiration_date":"2028-03-12","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-18-020017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919118020017/doc4.xml","form_type":"4"}},{"id":4119086,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":5,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":6,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":7,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":8,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":9,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2017-12-29T17:10:35.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":316163,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Company"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The exercise price per share for the warrant is equal to 105% of the volume weighted average price of the Issuer's common stock for the 30 calendar days following the closing date of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held directly by EQC Private Markets SAC Fund Ltd EQC Biotech Sely I Fund, (\"Sely I\"), a Bermuda mutual fund company.  Equilibria manages Sely I and may be deemed to beneficially hold shares held by such fund."}],"balance_after":316163,"derivative":{"expiration_date":"2022-12-29","underlying":"Common Stock","underlying_shares":316163},"source":{"system":"sec-edgar","filing":"0001209191-17-067657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919117067657/doc4.xml","form_type":"4"}},{"id":4119085,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":5,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":6,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":7,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":8,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":9,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-29T17:10:35.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":3343,"ownership":{"direct":false,"nature":"By Individual"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for common shares of SELLAS Life Sciences Group, Ltd (\"SELLAS\") in connection with the merger of SELLAS and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\").  On the effective date of the Merger, each common share of SELLAS was converted into 43.9972 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Shares held directly by Daniel Tafur (\"Mr. Tafur\").  Mr. Tafur is chief investment officer, founder and board member of Equilibria and may be deemed to beneficially own shares beneficially owned by Equilibria.  Mr. Tafur disclaims beneficial ownership of securities beneficially owned by Equilibria, except to the extent of any pecuniary interests therein."}],"balance_after":3343,"source":{"system":"sec-edgar","filing":"0001209191-17-067657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919117067657/doc4.xml","form_type":"4"}},{"id":4119084,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":5,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":6,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":7,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":8,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":9,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-29T17:10:35.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":3343,"ownership":{"direct":false,"nature":"By limited liability company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for common shares of SELLAS Life Sciences Group, Ltd (\"SELLAS\") in connection with the merger of SELLAS and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\").  On the effective date of the Merger, each common share of SELLAS was converted into 43.9972 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Varibobi Financial Holdings Limited, a Cyprus limited liability company (\"Varibobi\").  Varibobi is an owner of Equilibria and may be deemed to beneficially hold shares beneficially owned by Equilibria.  Fabio Lopez is the sole owner of Varibobi and the chief executive officer and a board member of Equilibria and may be deemed to be the indirect beneficial owner of the shares owned by Varibobi and Equilibria.  Mr. Lopez disclaims beneficial ownership of securities beneficially owned by Equilibria, except to the extent of any pecuniary interests therein."}],"balance_after":3343,"source":{"system":"sec-edgar","filing":"0001209191-17-067657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919117067657/doc4.xml","form_type":"4"}},{"id":4119083,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":5,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":6,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":7,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":8,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":9,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-29T17:10:35.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":58208,"ownership":{"direct":false,"nature":"By Company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for common shares of SELLAS Life Sciences Group, Ltd (\"SELLAS\") in connection with the merger of SELLAS and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\").  On the effective date of the Merger, each common share of SELLAS was converted into 43.9972 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held directly by EQC Private Markets II SAC Fund Ltd EQC Biotech Sely III Fund (\"Sely III\"), a Bermuda mutual fund company.  Equilibria manages Sely III and may be deemed to beneficially hold shares held by such fund."}],"balance_after":58208,"source":{"system":"sec-edgar","filing":"0001209191-17-067657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919117067657/doc4.xml","form_type":"4"}},{"id":4119082,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":5,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":6,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":7,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":8,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":9,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-29T17:10:35.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":325799,"ownership":{"direct":false,"nature":"By Company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for common shares of SELLAS Life Sciences Group, Ltd (\"SELLAS\") in connection with the merger of SELLAS and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\").  On the effective date of the Merger, each common share of SELLAS was converted into 43.9972 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held directly by EQC Private Markets SAC Fund Ltd EQC Biotech Sely II Fund, (\"Sely II\"), a Bermuda mutual fund company.  Equilibria manages Sely II and may be deemed to beneficially hold shares held by such fund."}],"balance_after":325799,"source":{"system":"sec-edgar","filing":"0001209191-17-067657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919117067657/doc4.xml","form_type":"4"}},{"id":4119081,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":5,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":6,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":7,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":8,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":9,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-29T17:10:35.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":676324,"ownership":{"direct":false,"nature":"By Company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for common shares of SELLAS Life Sciences Group, Ltd (\"SELLAS\") in connection with the merger of SELLAS and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\").  On the effective date of the Merger, each common share of SELLAS was converted into 43.9972 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held directly by EQC Private Markets SAC Fund Ltd EQC Biotech Sely I Fund, (\"Sely I\"), a Bermuda mutual fund company.  Equilibria manages Sely I and may be deemed to beneficially hold shares held by such fund."}],"balance_after":676324,"source":{"system":"sec-edgar","filing":"0001209191-17-067657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919117067657/doc4.xml","form_type":"4"}},{"id":4119080,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":5,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":6,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":7,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":8,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":9,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-29T17:10:35.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":1521863,"ownership":{"direct":false,"nature":"By Company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for common shares of SELLAS Life Sciences Group, Ltd (\"SELLAS\") in connection with the merger of SELLAS and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\").  On the effective date of the Merger, each common share of SELLAS was converted into 43.9972 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held directly by EQC Private Markets SAC Fund II Ltd EQC Biotech Sely S Fund (\"Sely S\"), a Bermuda mutual fund company.  Equilibria manages Sely S and may be deemed to beneficially hold shares held by such fund."}],"balance_after":1521863,"source":{"system":"sec-edgar","filing":"0001209191-17-067657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919117067657/doc4.xml","form_type":"4"}},{"id":4119079,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":163402,"kind":"person","name":"Lopez Fabio","position":1,"cik":"0001724449","reported_name":"Lopez Fabio","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163403,"kind":"organization","name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","position":2,"cik":"0001724585","reported_name":"EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163404,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","position":3,"cik":"0001724529","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163405,"kind":"organization","name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","position":4,"cik":"0001724530","reported_name":"EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163410,"kind":"organization","name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","position":5,"cik":"0001724539","reported_name":"EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163406,"kind":"organization","name":"Equilibria Capital Management Ltd","position":6,"cik":"0001724701","reported_name":"Equilibria Capital Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163407,"kind":"organization","name":"Castilian Ltd.","position":7,"cik":"0001724523","reported_name":"Castilian Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163408,"kind":"organization","name":"Varibobi Financial Holdings Ltd","position":8,"cik":"0001724811","reported_name":"Varibobi Financial Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163409,"kind":"person","name":"Tafur Daniel","position":9,"cik":"0001724558","reported_name":"Tafur Daniel","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-29T17:10:35.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":149766,"ownership":{"direct":false,"nature":"By limited liability company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for common shares of SELLAS Life Sciences Group, Ltd (\"SELLAS\") in connection with the merger of SELLAS and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\").  On the effective date of the Merger, each common share of SELLAS was converted into 43.9972 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Equilibria Capital Management Limited (\"Equilibria\"), a Bermuda limited liability company."}],"balance_after":149766,"source":{"system":"sec-edgar","filing":"0001209191-17-067657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724449/000120919117067657/doc4.xml","form_type":"4"}}]}